A team of scientists has developed the first mRNA bird-flu vaccine for cattle, which triggers a strong immune response to the virus and protects against infection in calves. This breakthrough could mark a crucial step towards creating influenza vaccines for livestock and reducing the risk of animal-to-human transmission of the bird flu virus, which poses a significant pandemic threat.
Forecast for 6 months: Within the next 6 months, we can expect to see further trials of the mRNA bird-flu vaccine for cattle, with a focus on testing its efficacy in lactating adult cattle. Additionally, health officials may implement stricter measures to contain the bird flu outbreaks in US poultry and cattle farms.
Forecast for 1 year: By the end of the year, we may see the approval of the mRNA bird-flu vaccine for cattle, paving the way for its widespread use in the livestock industry. This could lead to a significant reduction in the risk of animal-to-human transmission of the bird flu virus.
Forecast for 5 years: Within the next 5 years, we can expect to see the development of more effective and targeted influenza vaccines for livestock, including those that can be administered to poultry and other animals. This could lead to a significant reduction in the incidence of bird flu outbreaks and the associated risk of animal-to-human transmission.
Forecast for 10 years: By the end of the decade, we may see the eradication of bird flu in the US poultry and cattle industries, thanks to the widespread use of effective influenza vaccines and improved biosecurity measures. This could lead to a significant reduction in the risk of animal-to-human transmission of the virus and a major improvement in public health.
